Transient effectiveness of dapsone for skin lesions in a patient with discoid lupus erythematosus

Naoya Mikita, Fukumi Furukawa

Article ID: 565
Vol 2, Issue 1, 2018

VIEWS - 1091 (Abstract) 397 (PDF)

Abstract


Dapsone is a synthetic sulfone preparation and is second-line treatment for cutaneous lupus erythematosus (CLE) including discoid LE (DLE). This report describes a patient with DLE, which was improved by dapsone quickly but the recurrence was noted.  Oral administration of prednisolone (5 mg / day) was required but the complete healing was very difficult. In this report, we will discuss the effectiveness and limitation of dapsone   for patients with DLE and the mechanisms of action.


Keywords


dapsone; diaminodiphenyl sulfone; DDS; discoid lupus erythematosus

Full Text:

PDF


References


1. Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus erythematosus: Update of therapeutic options Part I. J Am Acad Dermatol 2011; 65(6): e179–193. doi: 10.1016/j.jaad.2010.06.018.

2. Okon LG, Werth VP. Cutaneous lupus erythe­matosus: Diagnosis and treatment. Best Pract Res Clin Rheumatol 2013; 27(3): 391–404. doi: 10.1016/j.berh.2013.07.008.

3. Klebes M, Wutte N, Aberer E. Dapsone as second-line treatment for cutaneous lupus erythematosus? A retrospective analysis of 34 patients and a review of the literature. Dermatology 2016; 232(1): 91–96. doi: 10.1159/000441054.

4. Elman SA, Joyce C, Nyberg F, et al. Developing classification criteria in discoid lupus erythe­matosus: Results of a Delphi execise. J Am Acad Dermatol 2017; 77(2): 261–267. doi: 10.1016/j.jaad.2017.02.030.

5. Yoshimasu T, Ohtani T, Sakamoto T, et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002; 12(1): 50–52.

6. Yokogawa N, Eto H, Tanikawa A, et al. Effects of hydroxy­chloroquine on cutaneous lupus erythematosus: A multi-center double-blind randomized parallel-group trial. Arthritis Rheumatol 2017; 69(4): 791–799. doi: 10.1002/art.40018.

7. Fukumi Furukawa. Hydroxychloroquine in lupus erythematosus, a new horizon of the old drug. Trends Immunother 2017; 1(3): 99–100. doi: 10.24294/ti.v1.i3.127

8. Hirakawa Y, Okuno A, Kimura D, et al. Hydroxy­chloroquine enhanced urticarial reaction in a patient with discoid lupus erythematosus. Trends Immunother 2017; 1(3): 121–123. doi.10.24294/ti.v1.i3.125

9. Wozel G, Blasum C. Dapsone in dermatology and beyond, Arch Dermatol Res 2014; 306(2): 103–124. doi: 10.1007/s00403-013-1409-7.

10. Nishimura H, Horiguchi Y, Matsumoto I, et al. Treatment of Behçet’s disease with diamino-diphenyl sulphone (DDS). J Dermatol Treat 1993; 4 (2): 77–79. doi: 10.3109/09546639309084519.

11. Lood C, Blanco LP, Purmalek MM, et al. Neu­trophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 2016; 22(2): 146–153. doi: 10.1038/nm.4027.




DOI: https://doi.org/10.24294/ti.v2.i1.565

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Fukumi Furukawa, Naoya Mikita

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This site is licensed under a Creative Commons Attribution 4.0 International License.